Pharmaceutical industry – Page 17
-
PodcastBoric acid
Mike Freemantle revisits battlefield surgery to investigate boric acid, a key part of Dakin's antiseptic solution used extensively in the first world war
-
ResearchRetrosynthetic algorithm broadened to design similar, but different, molecules
Chematica can now design efficient syntheses for large compound libraries
-
PodcastAmygdalin & Laetrile
Patrick Hughes delves into the molecule at the centre of a decades-old cancer treatment conspiracy theory
-
OpinionWill Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
NewsData manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
OpinionHas x-ray had its day?
Will the giant of structure determination be toppled by blasts from electron beams?
-
ArticleAccurate temperature control achieving big results, on a small scale
Radleys’ compact reaction station brings accurate temperature control to chemical scientists managing small-scale experiments
-
OpinionAre new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
BusinessEnhancing solvents' sustainability
Increased recycling and replacing toxic solvents with greener alternatives will reduce environmental impact
-
BusinessPfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
-
ArticleMultidisciplinary science kick starts innovation
Nanoform scientists discuss how their diverse personalities and scientific backgrounds foster innovation, helping them tackle problems from different angles, and design better processes
-
OpinionThe silent rise of the robots
Mechanical helpers have been creeping into our labs for decades
-
BusinessProfile: Oxford nanoSystems’ heat transfer coatings
Nanospiked coatings drastically increase heat exchangers’ efficiency and can be applied after manufacturing
-
OpinionGet with the quantum program
Now is the time for industry to engage with the emerging world of quantum computers
-
BusinessAbbVie to acquire Allergan in multibillion-dollar merger
Takeover deal will create world’s fifth-largest pharma company
-
OpinionIs this a golden age of new drug classes?
A host of new treatment modes are hitting the clinic and the market
-
BusinessIndustry adopts quantum computing, qubit by qubit
Companies looking to solve complex chemistry problems are among early adopters of quantum technology
-
BusinessChina makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
BusinessUS finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products